Corcept Therapeutics, Inc. (CORT) Reports Q3 EPS Loss of $0.08
- China's Central Bank Rocks Bitcoin; Says 'Not a Currency'
- Apple (AAPL), China Mobile (CHL) Sign iPhone Deal - WSJ
- GM (GM) to Pull Chevrolet Brand from European Market; Will Focus on 'Iconic' Models
- After Hours Stock Movers 12/4: (PBYI) (MFRM) (GGP) Higher; (LGP) (SNPS) (ARO) Lower (more...)
- General Growth Properties (GGP) Set to Join the S&P 500
Corcept Therapeutics, Inc. (NASDAQ: CORT) reported Q3 EPS of ($0.08), $0.02 better than the analyst estimate of ($0.10).
You May Also Be Interested In
- Guess?, Inc. (GES) Tops Q3 EPS by 4c; Guides Q4, FY14 EPS and Revs
- New York & Co., Inc. (NWY) Misses Q3 EPS by 1c, Offers Guidance
- Brown-Forman Corp. (BF-A) Reports Q2 EPS of $0.96
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!